A panel of the Disciplinary Tribunal, by majority decision, has today found that Tobi Amusan has not committed an Anti-Doping Rule Violation (ADRV) of three Whereabouts Failures within a 12-month period.
AIU Head Brett Clothier has indicated the Athletics Integrity Unit (AIU) is disappointed by this decision and will review the reasoning in detail before deciding whether to exercise its right of appeal to the Court of Arbitration for Sport (CAS) within the applicable deadline. The decision is currently confidential but will be published in due course.
Amusan’s provisional suspension has now been lifted with immediate effect.
- Dr Richard Freeman violated the UK Anti-Doping Rules by (1) taking possession of an order of 30 sachets of Testogel (i.e. testosterone gel) at the National Cycling Centre in Manchester, in May 2011, and (2) lying to UKAD in respect of that order.
- By way of a decision of the independent National Anti-Doping Panel in July 2023, Dr Freeman received a four-year ban from sport.
UK Anti-Doping (UKAD) has today confirmed that former British Cycling and Team Sky doctor Richard Freeman has been banned from all sport for four years after the independent National Anti-Doping Panel found he committed the Anti-Doping Rule Violations of ‘Possession of a Prohibited Substance’ and (on two distinct occasions) ‘Tampering’.
In September 2016, UKAD commenced an investigation after receiving information that a possible Anti-Doping Rule Violation may have been committed by individuals associated with Team Sky in connection with the Critérium du Dauphiné, a professional cycling event, in June 2011. The possible violation in question concerned the alleged contents of a package (widely referred to as ‘the Jiffy bag’) that was delivered to Dr Freeman at the end of the event.
During the course of UKAD’s investigations into those matters, UKAD’s investigators uncovered that a delivery of 30 Testogel sachets had been made to British Cycling’s Headquarters, at the Manchester Velodrome in May 2011. Testogel is a prescription-only medication that contains the banned substance testosterone which, under the UK Anti-Doping Rules, is prohibited at all times. Each of the violations proved by UKAD in its proceedings before the independent National Anti-Doping Panel concern this Testogel delivery.
As part of its investigation into the Testogel, UKAD interviewed Dr Freeman in February 2017. In interview, Dr Freeman claimed to have ordered the Testogel for a ‘non-rider’ member of British Cycling staff, but said that the Testogel had been returned to the supplier for destruction. Dr Freeman failed to name the ‘non-rider’ patient who he claimed the Testogel was for, relying on patient confidentiality. He claimed that he had written to the patient asking them to waive confidentiality and they had refused to consent to matters being discussed with UKAD. UKAD, however, continued to investigate matters relating to the Testogel – including in particular Dr Freeman’s account that the order had been placed for a ‘non-rider’ member of British Cycling staff. Evidence obtained by UKAD indicated that the Testogel had not been returned to the supplier as Dr Freeman claimed. In April 2017, UKAD made a referral to the General Medical Council (GMC) in respect of UKAD’s concerns relating to Dr Freeman’s conduct and fitness to practise.
The GMC then investigated Dr Freeman and went on to commence a case before the independent Medical Practitioners Tribunal Service (MPTS) in October 2019. In March 2021, an MPTS tribunal found proven the allegation that Dr Freeman ordered testosterone, ‘knowing or believing’ it to be for an unnamed rider in May 2011 to improve their athletic performance. It was also found proven that he had lied to UKAD under investigation when claiming that the Testogel had been ordered for a ‘non-rider’ patient and had been returned to the supplier. The MPTS tribunal erased Dr Freeman from the Medical Register, a decision which was subsequently upheld by the High Court on appeal by Dr Freeman.
On 22 December 2020 (whilst the MPTS hearing was ongoing), UKAD provisionally suspended Dr Freeman and charged him with the commission of Anti-Doping Rule Violations. He was charged with an Article 2.6 violation under the 2009 UK Anti-Doping Rules for ‘Possession of a Prohibited Substance’, namely testosterone, in connection with an Athlete, Event or training. UKAD also charged Dr Freeman with two separate Article 2.5 violations under the 2015 UK Anti-Doping Rules for ‘Tampering’. The first Tampering violation concerned Dr Freeman knowingly providing UKAD with false information that the Testogel had been returned to the supplier. The second Tampering violation concerned Dr Freeman knowingly providing UKAD with false information that he had written to a non-rider member of staff requesting that they waive patient confidentiality and claiming that they had refused to do so.
An independent tribunal of the National Anti-Doping Panel convened in July 2023 to consider UKAD’s case against Dr Freeman and found all charges proven. The tribunal was comfortably satisfied that Dr Freeman had ‘intended to make available to one or more of his athletes the Prohibited Substance delivered to the Manchester Velodrome'. Whilst Dr Freeman had accepted that he had lied to UKAD about returning the Testogel to the supplier, he maintained that he had written to a non-rider member of staff requesting that they waive patient confidentiality and that they had refused to do so. The independent tribunal found that UKAD had also proved the second Tampering violation against Dr Freeman whose ‘conduct subverted Doping Control'.
The independent tribunal of the National Anti-Doping Panel sanctioned Dr Freeman with a four-year ban, effective from 22 December 2020 (the date of his provisional suspension), making him ineligible to participate in any World Anti-Doping Code-compliant sport until 21 December 2024.
Jane Rumble, UKAD’s Chief Executive added, “The decision of the independent tribunal of the National Anti-Doping Panel confirms that Richard Freeman broke the UK Anti-Doping Rules. The rules are in place to make sure everyone plays their part in keeping sport clean and to ensure a level playing field.
“The outcomes of both UKAD and the GMC’s respective investigations were vital to outing the truth in this matter. This case sends a strong message to all athlete support personnel that the rules apply equally to them, just as they do to athletes, and that they have a clear responsibility to uphold the values of integrity in sport. When they fail to do so, every effort will be taken to ensure that the rules are enforced.”
Mario Theophanous, Head of UKAD’s Intelligence and Investigations Team, who led UKAD’s investigation into Dr Freeman:
“This was a complex and comprehensive investigation to ascertain whether any wrongdoing had been committed, working with individuals who bravely came forward to give information to protect the values of their sport.
Every piece of information, no matter how small, can make the difference in a complex case like this, building enough evidence to hold to account those who choose to break the rules. I would like to place on record my thanks to all those individuals who placed their trust in UKAD and provided evidence that led to this result. I encourage anyone who has concerns around doping activity in sport, to report it to UKAD via our Protect Your Sport initiative.”
Frank Slevin, British Cycling Chair said: “We note today's verdict from the National Anti-Doping Panel and thank them for the time and consideration put into reaching their decision. Throughout this case we have reiterated our belief that it is in public interest that all matters are heard and thoroughly examined, and have made every effort to support both UK Anti-Doping and the General Medical Council in their respective investigations.
“As we have stated previously, Richard Freeman’s conduct during his employment by British Cycling bore no resemblance to the high ethical and professional standards which we, our members and our partners rightly expect.”
Commission on preliminary consideration of anti-doping rules violations of RAA RUSADA rendered the decision that made athlete Danilov Sergey (bodybuilding) ineligible for 4 years for violation under cl. 4.3 of the All-Russian Anti-Doping Rules. The period of ineligibility is commencing on the date of the decision, namely on July 24, 2023, with credit for the served period of provisional suspension, namely from April 26, 2023.
Commission on preliminary consideration of anti-doping rules violations of RAA RUSADA rendered the decision that made athlete Yatsunenko Aleksandr (American football) ineligible for 5 years for violation under cl. 4.1, cl. 4.2 and cl. 4.5 of the All-Russian Anti-Doping Rules. The period of ineligibility is commencing on the date of the decision, namely on July 24, 2023, with credit for the served period of provisional suspension, namely from May 31, 2023.
THE INTERNATIONAL TESTING AGENCY (ITA) REPORTS THAT THE SRI LANKAN RIDER MATHILDA KARLSSON HAS BEEN SANCTIONED WITH A 19-MONTH PERIOD OF INELIGIBILITY AFTER MISSING THREE ANTI-DOPING CONTROLS WITHIN A TWELVE-MONTH PERIOD.
The ITA, on behalf of the Fédération Équestre Internationale (FEI), confirms that Mathilda Karlsson has been suspended for a 19-month period, effective until 14 January 2025 after committing three whereabouts failures within a twelve-month period as defined in article 2.4 of the FEI ADRHA.
The case was resolved via an agreement on consequences pursuant to article 8.3.1 of the FEI Anti-Doping Rules for Human Athletes (FEI ADRHA), and equivalent provision in the World Anti-Doping Code.
The athlete qualified for a reduction of the otherwise two-year period ineligibility pursuant to article 10.3.2 of the FEI ADRHA which provides that the sanction can be reduced to a minimum of one year depending on the athlete’s degree of fault. The athlete’s results will be disqualified from 20 November 2022 until the start of the athlete’s provisional suspension on 15 June 2023.
-
Most comprehensive programme ever implemented in competition’s history
-
All 835 tests conducted in and out of competition by FIFA yield negative results
-
More than 25% increase in tests per team compared to France 2019
FIFA has implemented the most comprehensive FIFA Women’s World Cup™ anti-doping programme ever, with the 835 in- and out-of-competition tests conducted up to and including the quarter-finals yielding negative results.
Every participating team was tested in unannounced doping controls before the competition and further systematic tests have also been performed during the event, with post-match controls as well as tests on non-matchdays for the teams. With the aim of ensuring the most meaningful and intelligence-based programme, all tests were targeted based on key criteria, including recommendations from FIFA’s Athlete Passport Management Unit, potential injuries suffered by the players, performance data and the players’ testing history.
The testing programme has been implemented in coordination with Sport Integrity Australia (SIA) and Drug Free Sport New Zealand (DFSNZ), with FIFA’s Athlete Passport Management Unit, composed of independent experts, reviewing player data to detect potential deviations that may indicate the abuse of performance-enhancing drugs.
The breakdown of test figures from the lead-up to and during the FIFA Women’s World Cup 2023™ is as follows:
-
835 tests conducted directly by FIFA – 449 pre-tournament and 386 during the tournament (up to and including the quarter-finals); additional tests implemented by national anti-doping organisations and the confederations in 2023
-
1,711 samples produced in the tests conducted by FIFA (824 urine, 415 blood, 409 blood passport and 63 dried blood spot samples)
-
More than 25% increase in tests conducted per participating team in comparison to the FIFA Women’s World Cup France 2019™
-
All 32 participating teams were tested in advance of the tournament
All samples collected were analysed at WADA-accredited laboratories, with most of the analyses carried out at the laboratory in Sydney, Australia.
